| Select | PubMed ID | Description |
| 22092996 | Clin Exp Allergy. 2011 Dec;41(12):1804-14. doi:
1111/j.1365-2222.2011.03866.x. Epub 2011 Sep 23.
Bet v 1-like pollen allergens of multiple Fagales species can sensitize atopic
individuals.
Hauser M(1), Asam C, Himly M, Palazzo P, Voltolini S, Montanari C, Briza P,
Bernardi ML, Mari A, Ferreira F, Wallner M.
|
| 33724487 | Allergy. 2021 Aug;76(8):2555-2564. doi: 10.1111/all.14817. Epub 2021 May 6.
IgE-cross-blocking antibodies to Fagales following sublingual immunotherapy with
recombinant Bet v 1.
Grilo JR(1), Kitzmüller C(1), Aglas L(2), Sánchez Acosta G(1), Vollmann U(1),
Ebner C(3), Horak F(4), Kinaciyan T(5), Radauer C(1), Ferreira F(2), Jahn-Schmid
B(1), Bohle B(1).
|
| 34837242 | Allergy. 2022 Jun;77(6):1751-1760. doi: 10.1111/all.15191. Epub 2021 Dec 16.
Isolation of nanobodies with potential to reduce patients' IgE binding to Bet v
Zettl I(1), Ivanova T(2), Strobl MR(3), Weichwald C(1), Goryainova O(2), Khan
E(2), Rutovskaya MV(2)(4), Focke-Tejkl M(1), Drescher A(5), Bohle B(3), Flicker
S(1), Tillib SV(2).
|
| 36424884 | Allergy. 2022 Nov 24. doi: 10.1111/all.15594. Online ahead of print.
Bet v 1-independent sensitization to major allergens in Fagales pollen: Evidence
at the T-cell level.
Polak D(1), Vollmann U(1), Grilo J(1), Bogdanov IV(2), Aglas L(3), Ovchinnikova
TV(2), Ferreira F(3), Bohle B(1).
|
